Phibro Animal Health (PAHC) Invested Capital (2013 - 2026)

Phibro Animal Health's Invested Capital history runs 14 years deep, the most recent figure standing at $384.7 million for Q1 2026.

• In Q1 2026, Invested Capital rose 36.29% year-over-year to $384.7 million; the TTM figure through Mar 2026 stood at $384.7 million (up 36.29% YoY), while the FY2025 annual figure was $301.9 million, up 5.41% from the prior year.
• Invested Capital was $384.7 million for Q1 2026 at Phibro Animal Health, up from $353.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $384.7 million in Q1 2026 to a low of $263.1 million in Q4 2024.
• Historically, Invested Capital has averaged $298.5 million across 5 years, with a median of $287.7 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Invested Capital decreased 11.38% in 2024, then soared 36.29% in 2026.
• A 5-year view of Invested Capital shows it stood at $283.8 million in 2022, then grew by 4.6% to $296.8 million in 2023, then fell by 11.38% to $263.1 million in 2024, then surged by 34.19% to $353.0 million in 2025, then rose by 8.97% to $384.7 million in 2026.
• The last three Invested Capital figures came in at $384.7 million (Q1 2026), $353.0 million (Q4 2025), and $330.1 million (Q3 2025), per Business Quant data.